Table 3.
Complications and adverse events
| Variable | URSL group | MPCNL group | RPUL group | P valuea | P valueb | P valuec |
|---|---|---|---|---|---|---|
| Grade I | ||||||
| Pain | 6/46(13%) | 8/50(16%) | 9/48(18%) | 0.276 | 0.027 | 0.795 |
| Fever | 2/46(4.3%) | 3/50(6%) | 2/48(4.2%) | 0.735 | 0.658 | 0.743 |
| Nausea/vomiting | 2/46(4.3%) | 1/50(2%) | 3/48(6%) | 0.273 | 0.342 | 0.042 |
| Urine leakage | 0/46(0%) | 0/50(0%) | 3/48(6%) | NS | <0.001 | <0.001 |
| Grade II | ||||||
| Minor pelvic/ureter perforation | 3/46(6.5%) | 0/50(0%) | 0/48(0%) | <0.001 | <0.001 | NS |
| Urinary tract infection | 1/46(3%) | 1/50(2%) | 0/48(0%) | NS | <0.001 | <0.001 |
| Ureteral stricture | 2/46(4.3%) | 0/50(0%) | 0/48(0%) | <0.001 | <0.001 | NS |
| Grade III | ||||||
| Blood transfusion | 0/46(0%) | 3/50(6%) | 0/48(0%) | <0.001 | NS | <0.001 |
| Grade III - V | 0/46(0%) | 0/50(0%) | 0/48(0%) | NS | NS | NS |
aURSL vs. MPCNL; bURSL vs. RPUL; c MPCNL vs. RPUL; NS No Significance